文献速递中医内科中药与中成药合理使用

病毒亲和超滤结合血清药物化学鉴定甘草抗病毒药效物质

Combining virus-based affinity ultrafiltration method with serum pharmacochemistry to identify the antiviral pharmacodynamic substances in licorice.
PubMed 文献 · J Ethnopharmacol · 2024-10-20

该研究通过体内外实验确认甘草对H1N1和RSV的抗病毒作用,并首次联合病毒亲和超滤法与血清药物化学,鉴定出甘草中抗H1N1的药效物质为甘草酸、甘草次酸、异甘草素和glyasperin A(靶向M2离子通道),抗RSV的药效物质为licochalcone A和glyasperin A(靶向RSV表面蛋白)。

要点

  • 甘草体内外均能减轻H1N1和RSV感染小鼠的体重下降和肺损伤,降低肺病毒载量。
  • 甘草抗H1N1药效物质包括甘草酸、甘草次酸、异甘草素和glyasperin A。
  • 甘草抗RSV药效物质为licochalcone A和glyasperin A,靶向病毒表面蛋白。

核心结论

  • 甘草通过「多成分、多靶点」机制发挥抗H1N1和RSV作用,病毒亲和超滤联合血清药物化学可有效鉴定其药效物质。

研究设计与样本

  • 研究采用体内外实验验证甘草抗病毒效果,并联合病毒亲和超滤法与血清药物化学筛选药效物质及分子靶点。

主要发现

  • 体内实验显示甘草减轻H1N1和RSV感染小鼠的体重下降和肺组织损伤,并降低肺内病毒载量。
  • 体外实验证实甘草中存在直接抑制H1N1和RSV的原始化合物。
  • 抗H1N1药效物质为甘草酸、甘草次酸、异甘草素和glyasperin A,其中glyasperin A靶向M2离子通道。
  • 抗RSV药效物质为licochalcone A和glyasperin A,靶向RSV表面蛋白。

关键数值与推荐

  • 甘草酸、甘草次酸、异甘草素和glyasperin A为抗H1N1药效物质。
  • licochalcone A和glyasperin A为抗RSV药效物质,靶向RSV表面蛋白。
  • glyasperin A靶向M2离子通道发挥抗H1N1作用。

临床怎么用

  • 甘草可作为抗H1N1和RSV的候选中药,其药效物质群为多成分组合。
  • 病毒亲和超滤联合血清药物化学策略可用于中药抗病毒药效物质筛选。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Liorice (Glycyrrhiza uralensis Fisch.), a widely used Chinese herbal medicine, is frequently employed in clinical practice to treat viral pneumonia. However, the pharmacodynamic substances and mechanisms of action responsible for its antiviral effects against H1N1 and RSV remain unclear. AIM OF THE STUDY: To investigate the antiviral effects of licorice against H1N1 and RSV. Building on this, we aimed to more comprehensively and accurately identify the pharmacodynamic substances in licorice responsible for its antiviral activity and mechanisms of action against these two viruses. MATERIALS AND METHODS: Firstly, the antiviral effects of licorice against H1N1 and RSV were confirmed through in vivo and in vitro experiments. Then, a combination of virus-based affinity ultrafiltration method (VAUM) and serum pharmacochemistry were used to screen for pharmacological substances in licorice and identify their molecular targets against H1N1 and RSV. RESULTS: The in vivo experiments showed that licorice effectively alleviates H1N1 and RSV induced weight loss and lung tissue damage in mice, while also reducing viral loads of H1N1 and RSV in the lungs. Subsequent in vitro experiments confirmed the presence of original compounds in licorice that directly inhibit H1N1 and RSV. By combining both methods, glycyrrhizic acid, glycyrrhetinic acid (GA), isoliquiritigenin (ISL), and glyasperin A (targeting the M2 ion channel) were ultimately identified as the pharmacodynamic substances in licorice responsible for anti-H1N1 activity. Additionally, licochalcone A (LCA) and glyasperin A, which target RSV surface proteins, were identified as the pharmacodynamic substances responsible for anti-RSV activity. CONCLUSIONS: Traditional Chinese medicine (TCM) exerts its antiviral effects through a 'multi-component, multi-target' mechanism, which poses challenges for single active compound screening methods to adequately address. By integrating VAUM and serum pharmacochemistry for the first time, one approach focused on identifying compounds in TCM that directly bind to viral surface proteins, while the other targeted compounds that enter the bloodstream in their original form and exhibit antiviral activity. This provides a novel approach for studying the pharmacodynamic substances of antiviral effects in TCM.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Li Z, Dong M, Chen Z, et al. Combining virus-based affinity ultrafiltration method with serum pharmacochemistry to identify the antiviral pharmacodynamic substances in licorice. J Ethnopharmacol. 2024. PMID: 39433166. doi:10.1016/j.jep.2024.118978

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。